wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q57298628-8FD3BDFA-046E-4A54-979F-A91A08B1627F
Q57298628-8FD3BDFA-046E-4A54-979F-A91A08B1627F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57298628-8FD3BDFA-046E-4A54-979F-A91A08B1627F
The biosimilars journey: current status and ongoing challenges
P2860
Q57298628-8FD3BDFA-046E-4A54-979F-A91A08B1627F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57298628-8FD3BDFA-046E-4A54-979F-A91A08B1627F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
736c3da6cd9ea417994f915678ed3b082e20daf3
P2860
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.